Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Muhammad Mustafa, Aiman Tariq, Muhammad Khisroon, Aiman Mehroon, Aaliya Saleem, Bushra Arshad
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Time‐Dependent Response of Daunorubicin on Cytotoxicity, Cell Cycle, and DNA Repair in Acute Lymphoblastic Leukaemia
10.1186/s12885-019-5377-y · 2019
Improving Prediction of Blood Cancer Using Leukemia Microarray Gene Data and Chi2 Features With a Weighted Convolutional Neural Network
10.1038/s41598-024-65315-7 · 2024
10.5772/intechopen.91507
10.5772/intechopen.91507 · 2021
DNA Repair: Monitoring by the Comet Assay
2009
10.5812/mejrh‐141053
10.5812/mejrh‐141053
Therapy‐Related Myelodysplasia and Acute Myeloid Leukemia
2013
Effect of the Flavanolignans of Silybum marianum L. on Lipid Peroxidation in Rat Liver Microsomes and Freshly Isolated Hepatocytes
10.1016/1043-6618(92)91383-r · 1992
Fourth International Workgroup on Genotoxicity Testing: Results of the In Vivo Comet Assay Workgroup
10.1016/j.mrgentox.2006.08.011 · 2007
Silybin Dihemisuccinate Protects Against Glutathione Depletion and Lipid Peroxidation Induced by Acetaminophen in the Rat Liver
10.1055/s-2006-962055 · 2008
unpaywall
Confidence 95%
datacite
Confidence 0%
Protective Effects of Silymarin Against Doxorubicin‐Induced Toxicity
2011
Measuring DNA Modifications With the Comet Assay: A Compendium of Protocols
10.1038/s41596-022-00754-y · 2023
Oxidative DNA Damage, Antioxidants, and Cancer
10.1002/(sici)1521-1878(199903)21:3<238::aid-bies8>3.0.co;2-3 · 1999
Controlling Variation in the Comet Assay
10.3389/fgene.2014.00359 · 2014
Role of Hydrogen Peroxide and Hydroxyl Radical Formation in the Killing of Ehrlich Tumor Cells by Anticancer Quinones
10.1073/pnas.83.12.4514 · 1986
Unresolved referenced work
2018
Mapping Genes That Contribute to Daunorubicin‐Induced Cytotoxicity
10.1158/0008-5472.can-06-4431 · 2007
Protection Against Oxidative Damage of Erythrocyte Membrane by Silymarin
2001
Unresolved referenced work
2018
10.5772/35079
10.5772/35079 · 2012
10.1002/9780470571224
10.1002/9780470571224 · 2010
A Critical Evaluation of the Mechanisms of Action Proposed for the Antitumor Effects of the Anthracycline Antibiotics Adriamycin and Daunorubicin
10.1016/s0006-2952(98)00307-4 · 1999
Biochemistry of Multidrug Resistance Mediated by the Multidrug Transporter
10.1146/annurev.bi.62.070193.002125 · 1993
Antineoplastic Drugs and Their Analysis: A State‐Of‐The‐Art Review
10.1039/c7an00367f · 2017
Use of Human Peripheral Blood Lymphocytes to Measure DNA‐Binding Capacity of Chemical Carcinogens
10.1073/pnas.85.10.3513 · 1988
An Emerging Trend of Rapid Increase of Leukemia, but Not All Cancers, in the Aging Population in the United States
10.1038/s41598-019-48445-1 · 2019
An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes Through Antioxidant Response Elements
10.1006/bbrc.1997.6943 · 1997
Silymarin and Skin Cancer Prevention: Anti‐Inflammatory, Antioxidant, and Immunomodulatory Effects
2005
Silymarin and Epithelial Cancer Chemoprevention: How Close Are We to Bedside?
10.1016/j.taap.2006.11.011 · 2007
Effect of the Anticancer Drug Doxorubicin (Adriamycin) on Antioxidant Studies and Ultrastructural Investigation in the Liver, Kidney, and Heart Tissues of Male Rats
10.13005/bbra/3089 · 2023
Milk Thistle Nomenclature: Why It Matters in Cancer Research and Pharmacokinetic Studies
10.1177/1534735407301825 · 2007
The Current Situation and Future Trend of Leukemia Mortality by Sex and Area in China
10.3389/fpubh.2020.598215 · 2020
Silybin and the Liver: From Basic Research to Clinical Practice
10.3748/wjg.v17.i18.2288 · 2011
Acute Myeloid Leukemia
10.1056/nejm199909303411407 · 1999
Anti‐Cancer Alternative Therapies: From Inorganic Nanoparticles to Tumor‐Killing Bacteria
10.25083/rbl/27.2/3416.3421 · 2022
High Micronucleus Frequency in Peripheral Blood Lymphocytes of Untreated Cancer Patients Irrespective of Gender, Smoking, and Cancer Sites
10.1620/tjem.220.115 · 2010
Minimum Information for Reporting on the Comet Assay (MIRCA): Recommendations for Describing Comet Assay Procedures and Results
10.1038/s41596-020-0398-1 · 2020
10.20944/preprints202105.0429.v1
10.20944/preprints202105.0429.v1
Association of Chemotherapy for Solid Tumors With Development of Therapy‐Related Myelodysplasia and Acute Myeloid Leukemia in the Modern Era
2013
Nrf2‐Keap1 Defines a Physiologically Important Stress Response Mechanism
10.1016/j.molmed.2004.09.003 · 2004
Effect of Silimarin (Legalon) Therapy on the Antioxidant Defense Mechanism and Lipid Peroxidation in Alcoholic Liver Disease (Double Blind Protocol)
1990
Mechanistic Insights Into the Pharmacological Significance of Silymarin
10.3390/molecules27165327 · doi-reference
Hepatoprotective Effect of Silymarin
10.4254/wjh.v6.i3.144 · doi-reference
Antioxidant Properties of the Flavonoids Silybin and (+)‐Cyanidanol‐3: Comparison With Butylated Hydroxyanisole and Butylated Hydroxytoluene
10.1055/s-2007-969247 · doi-reference
Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review
10.14218/jcth.2020.00012 · doi-reference
Single Cell Gel/Comet Assay: Guidelines for In Vitro and In Vivo Genetic Toxicology Testing
10.1002/(sici)1098-2280(2000)35:3<206::aid-em8>3.0.co;2-j · doi-reference
Congestive Heart Failure in Patients Treated With Doxorubicin: A Retrospective Analysis of Three Trials
10.1002/cncr.11407 · doi-reference
Anthracycline‐Induced Cardiotoxicity and Renin‐Angiotensin‐Aldosterone System: From Molecular Mechanisms to Therapeutic Applications
10.1007/s10741-020-09977-1 · doi-reference
Doxorubicin‐Induced Cardiomyopathy
10.1056/nejm199809243391307 · doi-reference
Differences in the Disposition of Silymarin Between Patients With Nonalcoholic Fatty Liver Disease and Chronic Hepatitis C
10.1124/dmd.111.040212 · doi-reference
Silymarin as a Phytopharmaceutical Agent: Advances in Mechanistic Insights, Formulation Strategies, and Pre‐Clinical Applications
10.3389/fphar.2025.1711653 · doi-reference
The Use of Silymarin in the Treatment of Liver Diseases
10.2165/00003495-200161140-00003 · doi-reference
Exploring the Mechanisms and Dosages of Herbal Hepatoprotective Agents
10.5530/pres.16.4.82 · doi-reference
Treatment of Acute Lymphoblastic Leukemia
10.1056/nejmra052603 · doi-reference
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
10.1016/j.chembiol.2010.04.012 · doi-reference
Classification of Anticancer Drugs: An Update With FDA‐ and EMA‐Approved Drugs
10.1007/s10555-024-10188-5 · doi-reference
The Use of Isolated Peripheral Lymphocytes and Human Whole Blood in the Comet Assay
10.1038/protex.2016.076 · doi-reference
10.1787/9789264264885-en
10.1787/9789264264885-en · doi-reference